Drug Causes of changing commodity marketing channels and strategies analyzing.docVIP

 PAGE \* MERGEFORMAT 14 Drug Causes of changing commodity marketing channels and strategies analyzing Write papers Net: [Abstract] proposed drug marketing channel conflict from generation to start, focused on analyzing the type of R amp; D center, resulting in FALSIFYING reasons, and proposed solutions FALSIFYING problem. [Keywords] drug marketing; FALSIFYING FALSIFYING behavior at this stage the vast majority of Chinese pharmaceutical enterprises in the channel management problems. FALSIFYING, also known as red goods, that is, cross-border pharmaceutical sales, channel management is the bottleneck issue, but also present a number of pharmaceutical companies and even some well-known business sales illnesses encountered in the work one. First, the classification of FALSIFYING 1 malignant FALSIFYING Pharmaceutical companies or agents in order to obtain non-normal profits, deliberately outside its designated area of ??pharmaceutical marketing products, sales of other distributors and network regions seriously affected, resulting in intense channel conflict. FALSIFYING usually malignant lower than specified by the manufacturer Chu Huojia sales to other regions, it has established distribution channels with strong destructive, endangering the survival of the sales network of one of the biggest risks. (2) Nature of R amp; D center Pharmaceutical companies or agents to obtain normal profits, inadvertently dumped outside their own area to act as natural medicines of FALSIFYING usually manifestations of the adjacent area of ??R amp; D center near the border each other, based on the market in the circulation drugs with the logistics to the dumping to other areas and it will lead to regional and district boundary wholesalers profit decline, affecting their motivation. Severe may develop between two vicious FALSIFYING wholesalers, drug logistics to flow with the other regions, a large volume of the region will affect the price, resulting i